Picture Campus Berlin-Buch at BIO2023 Location of Future Innovation 650x100px
Person › Details

Sebastian Søderberg (Bactolife A/S)

Søderberg, Sebastian (Bactolife 202301– CEO formerly Novozymes)


Organisations Organisation Bactolife A/S
  Former/major organisation Novozymes A/S
  Group Novozymes (Group)
Products Product industrial biotechnology
  Product 2 Binding Proteins™

Bactolife A/S. (1/4/23). "Press Release: Bactolife Appoints Sebastian Søderberg New CEO". Copenhagen.

Bactolife announced today that Sebastian Søderberg has been appointed new CEO of the Bactolife as part of a planned succession. Sebastian is an experienced leader and entrepreneur within bio-industrial business and innovation. He will succeed Co-founder Mads Laustsen, who assumes the role as Strategic Advisor to Bactolife.

In addition to the CEO changes, Thomas Gadegaard has been appointed SVP of Finance & Accounting, and Julie Rastad SVP of Business Development & Marketing. Both are stepping into the Leadership Team as of 1 January 2023.

With the new Leadership Team in place, Bactolife is well equipped to take on the next chapter in our development and commercialization of Binding Proteins™ with the vision to empower health worldwide through a fortified gut microbiome.

Record changed: 2023-02-13


Picture EasyFairs Connect in Pharma 2023 Geneva Networking 650x200px

More documents for Sebastian Søderberg

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EasyFairs Connect in Pharma 2023 Geneva Agenda 650x300px

» top